With a pro-legalization pick for U.S. Attorney General and a pro-business tax agenda, some in the cannabis industry have found reason to be cautiously optimistic about President-elect Donald Trump’s second term. Akerman’s Cannabis Practice Chair, Jonathan Robbins, tells Forbes industry leaders are